Optimization of the antibody identification interval in a high‐volume transfusion centre
Vox Sanguinis · 2026-08 · 121 (8) · 1228-1234
DOI: 10.1111/vox.70290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 12.05.2026. Verfasst von Kanyapon Suksard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Isoantibodies, Blood Transfusion, Blood Grouping and Crossmatching. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Objectives No established standards currently exist regarding the optimal interval for repeating antibody identification. Considering both transfusion safety and resource constraints, this study aimed to investigate the feasibility of extending the interval between antibody identification tests in a high‐volume transfusion setting. Materials and Methods We retrospectively reviewed 153,526 records over a 7‐year period in which antibody identification was repeated at 7‐day intervals under current practice. Cases with autoantibodies, non‐specific antibodies, drug‐related antibodies, passive anti‐D from Rhesus immunoglobulin (RhIG) or unidentified antibodies were excluded. Time intervals to newly detected antibodies (0–7, 8–14, 15–21 and 22–30 days) were analysed in transfused patients with at least one pre‐existing antibody.
Results
A total of 5806 antibodies were detected from 4835 patients (3.15%). Of these, 217 antibodies were detected in 155 patients (3.21%) who were known to previously possess at least one antibody. Antibody development was most frequently detected at 8–14 days post transfusion (16 cases, 35.56%), followed by 22–30 days (14 cases, 31.11%), 15–21 days (10 cases, 22.22%) and 0–7 days (5 cases, 11.11%). The median time to new antibody detection was 15.5 days (interquartile range, 10–26 days).
Conclusion
This study proposes an optimal interval for antibody identification in settings with a high prevalence of transfusion‐dependent patients and resource constraints. A 14‐day interval has the potential to reduce personnel workload and costs while maintaining transfusion safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Zitieren
APA
Suksard, K., Teravichitchainan, U., Wanayutthasin, Y., Saengbuaphuan, C., Pojanasingchod, A., Permpikul, P., & Kittivorapart, J. (2026). Optimization of the antibody identification interval in a high‐volume transfusion centre. Vox Sanguinis, 121(8), 1228-1234. https://doi.org/10.1111/vox.70290
Vancouver
Suksard K, Teravichitchainan U, Wanayutthasin Y, Saengbuaphuan C, Pojanasingchod A, Permpikul P, et al. Optimization of the antibody identification interval in a high‐volume transfusion centre. Vox Sanguinis. 2026;121(8):1228-1234. doi:10.1111/vox.70290
BibTeX
@article{Suksard2026,
author = {Suksard, Kanyapon and Teravichitchainan, Usana and Wanayutthasin, Yuwadee and Saengbuaphuan, Chaichana and Pojanasingchod, Anyarin and Permpikul, Parichart and Kittivorapart, Janejira},
title = {Optimization of the antibody identification interval in a high‐volume transfusion centre},
journal = {Vox Sanguinis},
year = {2026},
volume = {121},
number = {8},
pages = {1228--1234},
doi = {10.1111/vox.70290}
}
EUVIMED